nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—KCNJ6—midbrain—Gilles de la Tourette syndrome	0.0193	0.0285	CbGeAlD
Halothane—RHO—nervous system—Gilles de la Tourette syndrome	0.017	0.0251	CbGeAlD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0165	0.051	CbGpPWpGaD
Halothane—RHO—central nervous system—Gilles de la Tourette syndrome	0.0163	0.0241	CbGeAlD
Halothane—KCNK3—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.016	0.0498	CbGpPWpGaD
Halothane—KCNK9—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.016	0.0498	CbGpPWpGaD
Halothane—KCNJ3—midbrain—Gilles de la Tourette syndrome	0.0159	0.0235	CbGeAlD
Halothane—KCNJ6—nervous system—Gilles de la Tourette syndrome	0.0159	0.0234	CbGeAlD
Halothane—KCNK3—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0156	0.0483	CbGpPWpGaD
Halothane—KCNK9—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0156	0.0483	CbGpPWpGaD
Halothane—KCNJ6—central nervous system—Gilles de la Tourette syndrome	0.0153	0.0226	CbGeAlD
Halothane—KCNK18—nervous system—Gilles de la Tourette syndrome	0.015	0.0221	CbGeAlD
Halothane—KCNK3—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0145	0.045	CbGpPWpGaD
Halothane—KCNK9—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0145	0.045	CbGpPWpGaD
Halothane—KCNK18—central nervous system—Gilles de la Tourette syndrome	0.0144	0.0213	CbGeAlD
Halothane—GLRA1—nervous system—Gilles de la Tourette syndrome	0.0139	0.0206	CbGeAlD
Halothane—GLRA1—central nervous system—Gilles de la Tourette syndrome	0.0134	0.0198	CbGeAlD
Halothane—KCNJ3—nervous system—Gilles de la Tourette syndrome	0.0131	0.0193	CbGeAlD
Halothane—RHO—brain—Gilles de la Tourette syndrome	0.013	0.0192	CbGeAlD
Halothane—KCNJ3—central nervous system—Gilles de la Tourette syndrome	0.0126	0.0186	CbGeAlD
Halothane—KCNJ6—brain—Gilles de la Tourette syndrome	0.0121	0.0179	CbGeAlD
Halothane—GNG2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0118	0.0365	CbGpPWpGaD
Halothane—GNG2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0114	0.0355	CbGpPWpGaD
Halothane—GNG2—nervous system—Gilles de la Tourette syndrome	0.0109	0.0161	CbGeAlD
Halothane—GNG2—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0107	0.033	CbGpPWpGaD
Halothane—GNG2—central nervous system—Gilles de la Tourette syndrome	0.0105	0.0155	CbGeAlD
Halothane—KCNJ3—brain—Gilles de la Tourette syndrome	0.01	0.0148	CbGeAlD
Halothane—GNG2—brain—Gilles de la Tourette syndrome	0.00836	0.0123	CbGeAlD
Halothane—KCNK10—nervous system—Gilles de la Tourette syndrome	0.00834	0.0123	CbGeAlD
Halothane—KCNK9—nervous system—Gilles de la Tourette syndrome	0.00829	0.0122	CbGeAlD
Halothane—KCNK10—central nervous system—Gilles de la Tourette syndrome	0.00803	0.0119	CbGeAlD
Halothane—KCNK9—central nervous system—Gilles de la Tourette syndrome	0.00798	0.0118	CbGeAlD
Halothane—GLRB—midbrain—Gilles de la Tourette syndrome	0.00794	0.0117	CbGeAlD
Halothane—KCNK3—nervous system—Gilles de la Tourette syndrome	0.00753	0.0111	CbGeAlD
Halothane—KCNK3—central nervous system—Gilles de la Tourette syndrome	0.00725	0.0107	CbGeAlD
Halothane—GRIN3A—nervous system—Gilles de la Tourette syndrome	0.00689	0.0102	CbGeAlD
Halothane—GABRQ—nervous system—Gilles de la Tourette syndrome	0.00671	0.0099	CbGeAlD
Halothane—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00666	0.0207	CbGpPWpGaD
Halothane—GRIN3A—central nervous system—Gilles de la Tourette syndrome	0.00663	0.00978	CbGeAlD
Halothane—GRIN2A—midbrain—Gilles de la Tourette syndrome	0.00662	0.00977	CbGeAlD
Halothane—GLRB—nervous system—Gilles de la Tourette syndrome	0.00653	0.00963	CbGeAlD
Halothane—GABRQ—central nervous system—Gilles de la Tourette syndrome	0.00646	0.00953	CbGeAlD
Halothane—KCNK10—brain—Gilles de la Tourette syndrome	0.00638	0.00941	CbGeAlD
Halothane—KCNK9—brain—Gilles de la Tourette syndrome	0.00634	0.00935	CbGeAlD
Halothane—GLRB—central nervous system—Gilles de la Tourette syndrome	0.00629	0.00927	CbGeAlD
Halothane—GRIN2A—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00621	0.0193	CbGpPWpGaD
Halothane—KCNK2—brain—Gilles de la Tourette syndrome	0.00596	0.00879	CbGeAlD
Halothane—GABRD—midbrain—Gilles de la Tourette syndrome	0.00592	0.00874	CbGeAlD
Halothane—GABRG3—nervous system—Gilles de la Tourette syndrome	0.00588	0.00867	CbGeAlD
Halothane—KCNK3—brain—Gilles de la Tourette syndrome	0.00576	0.00849	CbGeAlD
Halothane—GABRG1—midbrain—Gilles de la Tourette syndrome	0.0057	0.00841	CbGeAlD
Halothane—GABRG3—central nervous system—Gilles de la Tourette syndrome	0.00566	0.00835	CbGeAlD
Halothane—GABRB1—midbrain—Gilles de la Tourette syndrome	0.00553	0.00816	CbGeAlD
Halothane—GRIN2A—nervous system—Gilles de la Tourette syndrome	0.00544	0.00803	CbGeAlD
Halothane—GRIN3A—brain—Gilles de la Tourette syndrome	0.00526	0.00777	CbGeAlD
Halothane—GRIN2A—central nervous system—Gilles de la Tourette syndrome	0.00524	0.00773	CbGeAlD
Halothane—ND1—nervous system—Gilles de la Tourette syndrome	0.00522	0.0077	CbGeAlD
Halothane—KCNMA1—midbrain—Gilles de la Tourette syndrome	0.00516	0.00762	CbGeAlD
Halothane—GABRQ—brain—Gilles de la Tourette syndrome	0.00513	0.00757	CbGeAlD
Halothane—ATP5D—midbrain—Gilles de la Tourette syndrome	0.00512	0.00755	CbGeAlD
Halothane—ATP2C1—midbrain—Gilles de la Tourette syndrome	0.00505	0.00745	CbGeAlD
Halothane—ND1—central nervous system—Gilles de la Tourette syndrome	0.00502	0.00741	CbGeAlD
Halothane—GLRB—brain—Gilles de la Tourette syndrome	0.00499	0.00736	CbGeAlD
Halothane—GABRD—nervous system—Gilles de la Tourette syndrome	0.00487	0.00718	CbGeAlD
Halothane—GABRD—central nervous system—Gilles de la Tourette syndrome	0.00469	0.00692	CbGeAlD
Halothane—GABRG1—nervous system—Gilles de la Tourette syndrome	0.00469	0.00691	CbGeAlD
Halothane—GABRA6—nervous system—Gilles de la Tourette syndrome	0.00466	0.00687	CbGeAlD
Halothane—GABRB1—nervous system—Gilles de la Tourette syndrome	0.00454	0.0067	CbGeAlD
Halothane—GABRA5—nervous system—Gilles de la Tourette syndrome	0.00452	0.00667	CbGeAlD
Halothane—GABRG1—central nervous system—Gilles de la Tourette syndrome	0.00451	0.00666	CbGeAlD
Halothane—GABRG3—brain—Gilles de la Tourette syndrome	0.00449	0.00663	CbGeAlD
Halothane—GABRA6—central nervous system—Gilles de la Tourette syndrome	0.00448	0.00662	CbGeAlD
Halothane—GABRB1—central nervous system—Gilles de la Tourette syndrome	0.00437	0.00645	CbGeAlD
Halothane—GABRA5—central nervous system—Gilles de la Tourette syndrome	0.00435	0.00642	CbGeAlD
Halothane—KCNMA1—nervous system—Gilles de la Tourette syndrome	0.00424	0.00626	CbGeAlD
Halothane—KCNN4—brain—Gilles de la Tourette syndrome	0.00424	0.00626	CbGeAlD
Halothane—GABRA3—nervous system—Gilles de la Tourette syndrome	0.00421	0.00621	CbGeAlD
Halothane—ATP5D—nervous system—Gilles de la Tourette syndrome	0.00421	0.00621	CbGeAlD
Halothane—GABRG2—midbrain—Gilles de la Tourette syndrome	0.00417	0.00616	CbGeAlD
Halothane—GABRB2—midbrain—Gilles de la Tourette syndrome	0.00417	0.00616	CbGeAlD
Halothane—GRIN2A—brain—Gilles de la Tourette syndrome	0.00416	0.00614	CbGeAlD
Halothane—ATP2C1—nervous system—Gilles de la Tourette syndrome	0.00415	0.00613	CbGeAlD
Halothane—KCNJ6—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00413	0.0128	CbGpPWpGaD
Halothane—GABRA4—nervous system—Gilles de la Tourette syndrome	0.0041	0.00605	CbGeAlD
Halothane—KCNMA1—central nervous system—Gilles de la Tourette syndrome	0.00409	0.00603	CbGeAlD
Halothane—GABRA3—central nervous system—Gilles de la Tourette syndrome	0.00405	0.00598	CbGeAlD
Halothane—ATP5D—central nervous system—Gilles de la Tourette syndrome	0.00405	0.00598	CbGeAlD
Halothane—ATP2C1—central nervous system—Gilles de la Tourette syndrome	0.004	0.0059	CbGeAlD
Halothane—ND1—brain—Gilles de la Tourette syndrome	0.00399	0.00589	CbGeAlD
Halothane—GABRA4—central nervous system—Gilles de la Tourette syndrome	0.00395	0.00582	CbGeAlD
Halothane—KCNJ3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00378	0.0117	CbGpPWpGaD
Halothane—GABRD—brain—Gilles de la Tourette syndrome	0.00372	0.00549	CbGeAlD
Halothane—GABRA1—midbrain—Gilles de la Tourette syndrome	0.00368	0.00544	CbGeAlD
Halothane—GABRG1—brain—Gilles de la Tourette syndrome	0.00358	0.00528	CbGeAlD
Halothane—GABRA6—brain—Gilles de la Tourette syndrome	0.00356	0.00525	CbGeAlD
Halothane—GABRB1—brain—Gilles de la Tourette syndrome	0.00347	0.00512	CbGeAlD
Halothane—GABRA5—brain—Gilles de la Tourette syndrome	0.00345	0.0051	CbGeAlD
Halothane—GABRG2—nervous system—Gilles de la Tourette syndrome	0.00343	0.00506	CbGeAlD
Halothane—GABRB2—nervous system—Gilles de la Tourette syndrome	0.00343	0.00506	CbGeAlD
Halothane—GABRB2—central nervous system—Gilles de la Tourette syndrome	0.0033	0.00487	CbGeAlD
Halothane—GABRG2—central nervous system—Gilles de la Tourette syndrome	0.0033	0.00487	CbGeAlD
Halothane—KCNMA1—brain—Gilles de la Tourette syndrome	0.00324	0.00479	CbGeAlD
Halothane—ATP5D—brain—Gilles de la Tourette syndrome	0.00322	0.00474	CbGeAlD
Halothane—GABRA3—brain—Gilles de la Tourette syndrome	0.00322	0.00474	CbGeAlD
Halothane—GABRB3—midbrain—Gilles de la Tourette syndrome	0.0032	0.00473	CbGeAlD
Halothane—ATP2C1—brain—Gilles de la Tourette syndrome	0.00317	0.00468	CbGeAlD
Halothane—KCNJ6—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00316	0.00982	CbGpPWpGaD
Halothane—GABRA4—brain—Gilles de la Tourette syndrome	0.00313	0.00462	CbGeAlD
Halothane—GABRA2—nervous system—Gilles de la Tourette syndrome	0.00313	0.00462	CbGeAlD
Halothane—GABRE—nervous system—Gilles de la Tourette syndrome	0.00311	0.00458	CbGeAlD
Halothane—GABRA1—nervous system—Gilles de la Tourette syndrome	0.00303	0.00447	CbGeAlD
Halothane—GABRA2—central nervous system—Gilles de la Tourette syndrome	0.00302	0.00445	CbGeAlD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00299	0.00928	CbGpPWpGaD
Halothane—GABRE—central nervous system—Gilles de la Tourette syndrome	0.00299	0.00441	CbGeAlD
Halothane—RHO—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00292	0.00905	CbGpPWpGaD
Halothane—GABRA1—central nervous system—Gilles de la Tourette syndrome	0.00292	0.0043	CbGeAlD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0029	0.00901	CbGpPWpGaD
Halothane—KCNJ3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00289	0.00898	CbGpPWpGaD
Halothane—NPSR1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00286	0.00888	CbGpPWpGaD
Halothane—RHO—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00283	0.00879	CbGpPWpGaD
Halothane—CYP2A6—brain—Gilles de la Tourette syndrome	0.00271	0.004	CbGeAlD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00271	0.0084	CbGpPWpGaD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00271	0.00839	CbGpPWpGaD
Halothane—RHO—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00264	0.00819	CbGpPWpGaD
Halothane—GABRB3—nervous system—Gilles de la Tourette syndrome	0.00263	0.00389	CbGeAlD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00263	0.00815	CbGpPWpGaD
Halothane—GABRG2—brain—Gilles de la Tourette syndrome	0.00262	0.00387	CbGeAlD
Halothane—GABRB2—brain—Gilles de la Tourette syndrome	0.00262	0.00387	CbGeAlD
Halothane—NPSR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00256	0.00794	CbGpPWpGaD
Halothane—GABRB3—central nervous system—Gilles de la Tourette syndrome	0.00254	0.00374	CbGeAlD
Halothane—KCNN4—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00246	0.00763	CbGpPWpGaD
Halothane—KCNK18—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00246	0.00763	CbGpPWpGaD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00245	0.0076	CbGpPWpGaD
Halothane—GABRA2—brain—Gilles de la Tourette syndrome	0.00239	0.00353	CbGeAlD
Halothane—GABRE—brain—Gilles de la Tourette syndrome	0.00237	0.0035	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00232	0.0072	CbGpPWpGaD
Halothane—GABRA1—brain—Gilles de la Tourette syndrome	0.00231	0.00342	CbGeAlD
Halothane—NPSR1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00228	0.00707	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00225	0.00699	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00221	0.00686	CbGpPWpGaD
Halothane—ALB—brain—Gilles de la Tourette syndrome	0.00216	0.00319	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0021	0.00651	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00206	0.00639	CbGpPWpGaD
Halothane—GABRB3—brain—Gilles de la Tourette syndrome	0.00201	0.00297	CbGeAlD
Halothane—KCNK10—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00201	0.00622	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00195	0.00604	CbGpPWpGaD
Halothane—KCNK2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00192	0.00595	CbGpPWpGaD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00189	0.00588	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00189	0.00586	CbGpPWpGaD
Halothane—KCNK9—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00186	0.00579	CbGpPWpGaD
Halothane—KCNK3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00186	0.00579	CbGpPWpGaD
Halothane—GNG2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00179	0.00554	CbGpPWpGaD
Halothane—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.00179	0.00263	CbGeAlD
Halothane—RHO—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00177	0.00548	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00176	0.00546	CbGpPWpGaD
Halothane—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.00172	0.00254	CbGeAlD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00171	0.00532	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00171	0.00532	CbGpPWpGaD
Halothane—GNG2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00171	0.00529	CbGpPWpGaD
Halothane—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.00168	0.00247	CbGeAlD
Halothane—GNG2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00166	0.00514	CbGpPWpGaD
Halothane—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.00161	0.00238	CbGeAlD
Halothane—RHO—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0016	0.00496	CbGpPWpGaD
Halothane—GNG2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00154	0.00479	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00456	CbGpPWpGaD
Halothane—GRIN2A—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00146	0.00452	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00144	0.00448	CbGpPWpGaD
Halothane—KCNMA1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00138	0.00427	CbGpPWpGaD
Halothane—GNG2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00137	0.00425	CbGpPWpGaD
Halothane—CYP2B6—brain—Gilles de la Tourette syndrome	0.00136	0.00201	CbGeAlD
Halothane—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00135	0.00199	CbGeAlD
Halothane—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00133	0.00196	CbGeAlD
Halothane—GLRB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00132	0.0041	CbGpPWpGaD
Halothane—GABRQ—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0013	0.00403	CbGpPWpGaD
Halothane—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.0013	0.00192	CbGeAlD
Halothane—GNG2—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0013	0.00403	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00129	0.00399	CbGpPWpGaD
Halothane—CYP2E1—brain—Gilles de la Tourette syndrome	0.00128	0.00189	CbGeAlD
Halothane—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00128	0.00188	CbGeAlD
Halothane—ND1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00125	0.00389	CbGpPWpGaD
Halothane—ATP5D—Metabolism—HDC—Gilles de la Tourette syndrome	0.00125	0.00389	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00125	0.00388	CbGpPWpGaD
Halothane—ATP2C1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00123	0.00382	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00117	0.00363	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00116	0.00361	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00116	0.0036	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00113	0.00352	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00112	0.00347	CbGpPWpGaD
Halothane—GRIN2A—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00112	0.00347	CbGpPWpGaD
Halothane—GABRG3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00107	0.00332	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00106	0.00328	CbGpPWpGaD
Halothane—GABRB1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00105	0.00327	CbGpPWpGaD
Halothane—GLRA1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00105	0.00324	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00103	0.0032	CbGpPWpGaD
Halothane—CYP2D6—brain—Gilles de la Tourette syndrome	0.00101	0.0015	CbGeAlD
Halothane—GNG2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.001	0.00311	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000998	0.0031	CbGpPWpGaD
Halothane—GABRA6—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000997	0.00309	CbGpPWpGaD
Halothane—GABRQ—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000996	0.00309	CbGpPWpGaD
Halothane—GNG2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000991	0.00307	CbGpPWpGaD
Halothane—GABRA4—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000985	0.00306	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000969	0.00301	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000934	0.0029	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000907	0.00281	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000903	0.0028	CbGpPWpGaD
Halothane—GABRB2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000901	0.00279	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00088	0.00273	CbGpPWpGaD
Halothane—GABRA5—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000875	0.00272	CbGpPWpGaD
Halothane—GABRA3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000859	0.00267	CbGpPWpGaD
Halothane—GABRA2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000845	0.00262	CbGpPWpGaD
Halothane—GABRB3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000839	0.0026	CbGpPWpGaD
Halothane—GABRG2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000824	0.00256	CbGpPWpGaD
Halothane—GABRG3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00082	0.00254	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00082	0.00254	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000815	0.00253	CbGpPWpGaD
Halothane—GABRB1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000808	0.00251	CbGpPWpGaD
Halothane—CYP2A6—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000781	0.00242	CbGpPWpGaD
Halothane—GABRA6—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000764	0.00237	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000755	0.00234	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000741	0.0023	CbGpPWpGaD
Halothane—GNG2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000736	0.00228	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00072	0.00223	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000691	0.00214	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00069	0.00214	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000671	0.00208	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00067	0.00208	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000658	0.00204	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000654	0.00203	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000647	0.00201	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000643	0.00199	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000632	0.00196	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000631	0.00196	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000625	0.00194	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000605	0.00188	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000584	0.00181	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000574	0.00178	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000567	0.00176	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000552	0.00171	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000536	0.00166	CbGpPWpGaD
Halothane—GABRQ—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000535	0.00166	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00053	0.00164	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000528	0.00164	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00052	0.00161	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000515	0.0016	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000484	0.0015	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000479	0.00149	CbGpPWpGaD
Halothane—GABRG3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000441	0.00137	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000437	0.00136	CbGpPWpGaD
Halothane—GABRB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000434	0.00135	CbGpPWpGaD
Halothane—GABRA6—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000411	0.00127	CbGpPWpGaD
Halothane—GABRA4—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000406	0.00126	CbGpPWpGaD
Halothane—GABRB2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000371	0.00115	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00037	0.00115	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00036	0.00112	CbGpPWpGaD
Halothane—GABRA3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000354	0.0011	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000348	0.00108	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000346	0.00107	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000339	0.00105	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000339	0.00105	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000337	0.00104	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000336	0.00104	CbGpPWpGaD
Halothane—ALB—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000334	0.00104	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000313	0.000972	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000304	0.000943	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000297	0.00092	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000283	0.000879	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000272	0.000842	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000266	0.000825	CbGpPWpGaD
Halothane—ALB—Metabolism—HDC—Gilles de la Tourette syndrome	0.000229	0.000709	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000198	0.000615	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000189	0.000586	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.000187	0.00058	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00017	0.000527	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000123	0.000383	CbGpPWpGaD
